Valbiotis Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Valbiotis stock has a consensus rating of "Strong Buy" and an average price target of €2.23. The average 1-year stock price forecast is 185.53% higher than the current stock price, while the lowest is €1.80 (+130.47%) and the highest is €2.66 (+240.59%).

Price Target: €2.23 (+185.53%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	€1.80	€2.23	€2.23	€2.66
Change	+130.47%	+185.53%	+185.53%	+240.59%

Analyst Ratings

The average analyst rating for Valbiotis stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

3.85M

from 905.00K

325.41%

from 905.00K

Revenue Next Year

13.25M

from 3.85M

244.16%

from 3.85M

EPS This Year

-0.23

from -0.47

EPS Next Year

-0.08

from -0.23

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	298.00K	785.00K	4.73M	176.00K	905.00K	3.85M
Revenue Growth	-90.36%	163.42%	502.93%	-96.28%	414.21%	325.41%
Operating Income	-8.41M	-11.99M	-7.16M	-10.43M	-9.49M	-8.65M
Net Income	-8.68M	-12.31M	-7.37M	-10.03M	-9.42M	-8.75M
EPS	-	-	-	-	-0.47	-0.23
Free Cash Flow	-4.29M	-4.78M	-5.52M	-8.67M	-4.68M	-9.25M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue	2026	2027	2028
High	4.6M
Avg	3.9M
Low	3.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	408.3%
Avg	325.4%
Low	242.5%

EPS Forecast

EPS	2026	2027	2028
High	-0.23
Avg	-0.23
Low	-0.23

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-